Cefaly

Focus: Cefaly is a Belgian biotech specializing in migraine treatment through external trigeminal nerve stimulation (eTNS) devices. The company operates as a focused device-based therapeutic player in the neurology space.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Cefaly

AI assessmentNot Hiring

No open roles listed right now. Follow Cefaly to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

8 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

CEFALY

Migraine

Growth

Flagship migraine prevention device; clinical validation ongoing via Phase 1 trial and retrospective real-world data collection.

CEFALY Active

Migraine

Help build intelligence for Cefaly

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage pipeline with 8 active trials exploring migraine, fibromyalgia, and pregnancy-related applications using proprietary eTNS technology
Specialized neurology focus in high-prevalence indication (migraine affects 15% of global population) with limited non-pharmaceutical competition
Device-based innovation pathway offers cross-functional opportunities spanning regulatory, clinical, commercial, and engineering disciplines

Watch Out For

No current job openings (0 active positions) suggests limited near-term hiring or potential organizational constraint
Early pipeline stage (only 1 Phase 1 trial; 7 exploratory programs) indicates uncertain clinical validation and lengthy path to revenue
Undisclosed financials, funding status, and employee count raise questions about company stability, cash runway, and growth trajectory

Generated by Claude from Cefaly's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Variant formulation in exploratory phase; represents line extension opportunity within core migraine franchise.

Pipeline & Clinical Trials

Cefaly

Fibromyalgia

N/A

Clinical Trials (1)

NCT02546362Cefaly® Device in the Treatment of Patients With Fibromyalgia.

N/A

Verum Cefaly® Abortive Program device

Migraine

N/A

Clinical Trials (1)

NCT03465904A Phase III Trial of e-TNS for the Acute Treatment of Migraine

N/A

external Trigeminal Nerve Stimulation

Pregnancy

N/A

Clinical Trials (1)

NCT06788977External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

N/A

Retrospective Study on the Use of CEFALY® Device During Migraine Attacks

Migraine

N/A

Clinical Trials (1)

NCT02616978Retrospective Study on the Use of CEFALY® Device During Migraine Attacks

N/A

CEFALY Active

Migraine

N/A

Clinical Trials (1)

NCT02590939Acute Treatment of Migraine With e-TNS

N/A

Cefaly® Abortive Program device

Migraine

N/A

Clinical Trials (1)

NCT03217968Abortive Treatment of Migraine With the Cefaly® Abortive Program Device

N/A

CEFALY

Migraine

N/A

Clinical Trials (1)

NCT02342743Open-trial on the Prevention of Chronic Migraines With the CEFALY Device

N/A

CEFALY

Migraine

Phase 1

Clinical Trials (1)

NCT02411513Acute Treatment of Migraine Using the CEFALY Device

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2008

Portfolio: 8 clinical trials

Top TAs: Neurology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Neurology

7 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 3 crawl cycles